Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 3
2013 1
2014 3
2015 8
2016 6
2017 4
2018 5
2019 6
2020 5
2021 1
2022 2
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management.
Sawamoto K, Álvarez González JV, Piechnik M, Otero FJ, Couce ML, Suzuki Y, Tomatsu S. Sawamoto K, et al. Int J Mol Sci. 2020 Feb 23;21(4):1517. doi: 10.3390/ijms21041517. Int J Mol Sci. 2020. PMID: 32102177 Free PMC article. Review.
Gene therapy for Mucopolysaccharidoses.
Sawamoto K, Chen HH, Alméciga-Díaz CJ, Mason RW, Tomatsu S. Sawamoto K, et al. Mol Genet Metab. 2018 Feb;123(2):59-68. doi: 10.1016/j.ymgme.2017.12.434. Epub 2017 Dec 26. Mol Genet Metab. 2018. PMID: 29295764 Free PMC article. Review.
Mucopolysaccharidosis IVA and glycosaminoglycans.
Khan S, Alméciga-Díaz CJ, Sawamoto K, Mackenzie WG, Theroux MC, Pizarro C, Mason RW, Orii T, Tomatsu S. Khan S, et al. Among authors: sawamoto k. Mol Genet Metab. 2017 Jan-Feb;120(1-2):78-95. doi: 10.1016/j.ymgme.2016.11.007. Epub 2016 Nov 29. Mol Genet Metab. 2017. PMID: 27979613 Free PMC article. Review.
Development of Bone Targeting Drugs.
Stapleton M, Sawamoto K, Alméciga-Díaz CJ, Mackenzie WG, Mason RW, Orii T, Tomatsu S. Stapleton M, et al. Among authors: sawamoto k. Int J Mol Sci. 2017 Jun 23;18(7):1345. doi: 10.3390/ijms18071345. Int J Mol Sci. 2017. PMID: 28644392 Free PMC article. Review.
Therapies for the bone in mucopolysaccharidoses.
Tomatsu S, Alméciga-Díaz CJ, Montaño AM, Yabe H, Tanaka A, Dung VC, Giugliani R, Kubaski F, Mason RW, Yasuda E, Sawamoto K, Mackenzie W, Suzuki Y, Orii KE, Barrera LA, Sly WS, Orii T. Tomatsu S, et al. Among authors: sawamoto k. Mol Genet Metab. 2015 Feb;114(2):94-109. doi: 10.1016/j.ymgme.2014.12.001. Epub 2014 Dec 9. Mol Genet Metab. 2015. PMID: 25537451 Free PMC article. Review.
Evading the AAV Immune Response in Mucopolysaccharidoses.
Piechnik M, Sawamoto K, Ohnishi H, Kawamoto N, Ago Y, Tomatsu S. Piechnik M, et al. Among authors: sawamoto k. Int J Mol Sci. 2020 May 13;21(10):3433. doi: 10.3390/ijms21103433. Int J Mol Sci. 2020. PMID: 32414007 Free PMC article. Review.
Critical review of current MPS guidelines and management.
Stapleton M, Hoshina H, Sawamoto K, Kubaski F, Mason RW, Mackenzie WG, Theroux M, Kobayashi H, Yamaguchi S, Suzuki Y, Fukao T, Tadao O, Ida H, Tomatsu S. Stapleton M, et al. Among authors: sawamoto k. Mol Genet Metab. 2019 Mar;126(3):238-245. doi: 10.1016/j.ymgme.2018.07.001. Epub 2018 Jul 7. Mol Genet Metab. 2019. PMID: 30143438 Review.
Bone-Specific Drug Delivery for Osteoporosis and Rare Skeletal Disorders.
Sawamoto K, Álvarez JV, Herreño AM, Otero-Espinar FJ, Couce ML, Alméciga-Díaz CJ, Tomatsu S. Sawamoto K, et al. Curr Osteoporos Rep. 2020 Oct;18(5):515-525. doi: 10.1007/s11914-020-00620-4. Curr Osteoporos Rep. 2020. PMID: 32845464 Free PMC article. Review.
38 results